Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Prospective analysis of the port-wine stain patient population in the Netherlands in light of novel treatment modalities.

van Raath MI, Bambach CA, Dijksman LM, Wolkerstorfer A, Heger M.

J Cosmet Laser Ther. 2018 Apr;20(2):77-84. doi: 10.1080/14764172.2017.1368669. Epub 2018 Jan 31.

PMID:
29384394
2.

Rotation flap restores volume after inferomedial breast cancer excision.

Read RL, Bambach CP, Snook KL.

ANZ J Surg. 2013 Jul;83(7-8):595-6. doi: 10.1111/ans.12294. No abstract available.

PMID:
23890313
3.

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.

Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M; PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubiński J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kjaer SK, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Høgdall CK, Høgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Dürst M, du Bois A, Dörk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA; Australian Ovarian Cancer Study Group; Australian Cancer Study, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Pearce CL.

Nat Commun. 2013;4:1628. doi: 10.1038/ncomms2629.

4.

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM; Australian Cancer Study; Australian Ovarian Cancer Study, Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang-Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek MS, Coetzee GA; Consortium of Investigators of Modifiers of BRCA1/2, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Easton DF, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher DA, Flanagan JM, Garcia-Closas M, Gentry-Maharaj A, Giles GG, Glasspool RM, Gonzalez-Bosquet J, Goodman MT, Gore M, Górski B, Gronwald J, Hall P, Halle MK, Harter P, Heitz F, Hillemanns P, Hoatlin M, Høgdall CK, Høgdall E, Hosono S, Jakubowska A, Jensen A, Jim H, Kalli KR, Karlan BY, Kaye SB, Kelemen LE, Kiemeney LA, Kikkawa F, Konecny GE, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Lim BK, Lin J, Lissowska J, Lu KH, Lubiński J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Raska P, Renner SP, Risch HA, Rodriguez-Rodriguez L, Rossing MA, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shridhar V, Shu XO, Shvetsov YB, Sieh W, Song H, Southey MC, Spiewankiewicz B, Stram D, Sutphen R, Teo SH, Terry KL, Tessier DC, Thompson PJ, Tworoger SS, van Altena AM, Vergote I, Vierkant RA, Vincent D, Vitonis AF, Wang-Gohrke S, Palmieri Weber R, Wentzensen N, Whittemore AS, Wik E, Wilkens LR, Winterhoff B, Woo YL, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Phelan CM, Iversen E, Schildkraut JM, Berchuck A, Fridley BL, Goode EL, Pharoah PD, Monteiro AN, Sellers TA, Gayther SA.

Nat Commun. 2013;4:1627. doi: 10.1038/ncomms2613.

5.

Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.

Ibiebele TI, Hughes MC, Nagle CM, Bain CJ, Whiteman DC, Webb PM; Study of Digestive Health and Australian Cancer Study.

Int J Cancer. 2013 Jul;133(1):214-24. doi: 10.1002/ijc.28016. Epub 2013 Feb 12.

6.

The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival.

Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC; Australian Cancer Study Clinical Follow-Up Study.

Int J Cancer. 2012 Sep 1;131(5):E759-68. doi: 10.1002/ijc.27420. Epub 2012 Feb 28.

7.

Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community.

Pandeya N, Green AC, Whiteman DC; Australian Cancer Study.

Dis Esophagus. 2012 Sep-Oct;25(7):573-83. doi: 10.1111/j.1442-2050.2011.01287.x. Epub 2011 Nov 30.

PMID:
22128757
8.

Dietary patterns and risk of oesophageal cancers: a population-based case-control study.

Ibiebele TI, Hughes MC, Whiteman DC, Webb PM; Australian Cancer Study.

Br J Nutr. 2012 Apr;107(8):1207-16. doi: 10.1017/S0007114511004247. Epub 2011 Sep 7.

PMID:
21899799
9.

Eating habits and risk of esophageal cancers: a population-based case-control study.

Ibiebele TI, Taylor AR, Whiteman DC, van der Pols JC; Australian Cancer Study.

Cancer Causes Control. 2010 Sep;21(9):1475-84. doi: 10.1007/s10552-010-9576-8. Epub 2010 May 14.

PMID:
20467799
10.

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers.

Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, Montgomery GW, Green AC, Hayward NK, Webb PM; Australian Cancer Study.

Gastroenterology. 2010 Jul;139(1):73-83; quiz e11-2. doi: 10.1053/j.gastro.2010.04.009. Epub 2010 Apr 14.

PMID:
20399210
11.

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.

Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG, Sidhu SB.

Clin Cancer Res. 2009 Dec 15;15(24):7684-7692.

12.

Outcomes of minimally invasive surgery for phaeochromocytoma.

Meyer-Rochow GY, Soon PS, Delbridge LW, Sywak MS, Bambach CP, Clifton-Bligh RJ, Robinson BG, Sidhu SB.

ANZ J Surg. 2009 May;79(5):367-70. doi: 10.1111/j.1445-2197.2009.04891.x.

PMID:
19566519
13.

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.

Sadeghi S, Bain CJ, Pandeya N, Webb PM, Green AC, Whiteman DC; Australian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1169-78. doi: 10.1158/1055-9965.EPI-07-2852.

14.

Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.

Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, Hayward NK, Webb PM, Whiteman DC; Australian Cancer Study.

Int J Cancer. 2008 Jul 1;123(1):174-80. doi: 10.1002/ijc.23410.

15.

The University of Sydney Endocrine Surgery Database: 50 years of data accrual.

Reeve TS, Ihre-Lundgren C, Poole AG, Bambach C, Barraclough B, Sidhu S, Sywak M, Edhouse P, Delbridge L.

ANZ J Surg. 2008 Jan-Feb;78(1-2):7-12. doi: 10.1111/j.1445-2197.2007.04349.x.

PMID:
18199199
16.

Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.

Pang TC, Bambach C, Monaghan JC, Sidhu SB, Bune A, Delbridge LW, Sywak MS.

ANZ J Surg. 2007 Sep;77(9):768-73.

PMID:
17685956
17.

Laparoscopic surgery is safe for large adrenal lesions.

Soon PS, Yeh MW, Delbridge LW, Bambach CP, Sywak MS, Robinson BG, Sidhu SB.

Eur J Surg Oncol. 2008 Jan;34(1):67-70. Epub 2007 May 29.

PMID:
17532597
18.

Adrenal surgery: an update.

Bambach CP.

ANZ J Surg. 2003 Oct;73(10):850-2. No abstract available.

PMID:
14525582
19.

Clinical and molecular aspects of adrenocortical tumourigenesis.

Sidhu S, Gicquel C, Bambach CP, Campbell P, Magarey C, Robinson BG, Delbridge LW.

ANZ J Surg. 2003 Sep;73(9):727-38. Review.

PMID:
12956790
20.

Bilateral subtotal laparoscopic adrenalectomy for phaeochromocytoma.

Sackett WR, Bambach CP.

ANZ J Surg. 2003 Aug;73(8):664-6. No abstract available.

PMID:
12887546

Supplemental Content

Loading ...
Support Center